ISRCTN89278733CompletedNot Applicable
Safety and efficacy of mycophenolate mofetil in pediatric renal transplantatio
Erasmus Medical Center (The Netherlands)0 sites44 target enrollmentStarted: December 1, 2006Last updated:
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 44
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. All Dutch children, receiving a first kidney transplant after 01/01/2000
- •2. Treated with initial immunosuppression corticosteroids, MMF and CsA, during the latter part of the study with addition of basiliximab
Exclusion Criteria
- •1. Not on triple therapy (prednisolone/CsA/MMF) at the end of the first year
- •2. More than one acute rejection episode
- •3. Rejection episode being not steroid sensitive
- •4. No written informed consent
Investigators
Similar Trials
Not yet recruiting
Phase 4
Study comparing the ability of two medications, namely oral tablets of mycophenolate mofetil and cyclophosphamide, in keeping disease well controlled in patients with frequently relapsing or steroid dependent nephrotic syndromeCTRI/2022/10/046891AIIMS New Delhi
Recruiting
Phase 3
Efficacy and safety of low dose mycophenolate mofetile for remission maintenance in ANCA-associated vasculitisANCA associated vasculitisJPRN-UMIN000005242Department of Medicine, Kidney Center, Tokyo Women's Medical University20
Not yet recruiting
Phase 4
comparing the productiveness of two different ointments in treating oral erosive lichen planusCTRI/2024/02/062184Dr L Krishna Prasad
Active, not recruiting
Phase 1
Evaluating the safety and efficacy of mycophenolate mofetil, daclizumab and a single, initial week of corticosteroids in combination with tacrolimus or sirolimus with continued steroid as mainstay immunosuppression in comparison to current standard immunosuppression (mycophenolate mofetil, tacrolimus and continued corticosteroids) in renal transplantation. - UK ELiTERenal TransplantationMedDRA version: 7.1Level: PTClassification code 10038533EUCTR2004-005055-33-GBBarts and the London NHS Trust
Completed
Not Applicable
Pharmacokinetic Study of mycophenolate mofetil combined with rituximab in patients with Childhood-onset Complicated Frequently Relapsing or Steroid-dependent Nephrotic SyndromeChildhood-onset Complicated Frequently Relapsing or Steroid-dependent Nephrotic SyndromeJPRN-UMIN000016764Japanese Study Group of Kidney Disease in Children79